Calendar Roche Holding AG Swiss Exchange

Equities

RO

CH0012032113

Market Closed - Swiss Exchange 09:01:30 26/04/2024 pm IST 5-day change 1st Jan Change
240 CHF +1.35% Intraday chart for Roche Holding AG +0.84% -8.19%

Chart calendar Roche Holding AG

d1554e4690208b82336a9.NOcvzCz_ZSEsx_mNED9B2HL1ZN1tJcPJTqiNFGCRCGY.eYgdhmfJN3lhprD3Y2gGgB6gBbYDRrK-eMb8fzLoTRJZvWXhf6smbRmVrA~581963402a5abb9ccb9d8ed18eb4e97b

Upcoming events on Roche Holding AG

14/05/2024 10:30 pm BofA Securities Health Care Conference
15/05/2024 12:30 pm Berenberg Diagnostics Conference
22/05/2024 05:00 pm Investor Day
22/05/2024 05:30 pm Investor Day
23/05/2024 11:30 am Deutsche Bank dbAccess European Champions Conference
29/05/2024 05:30 pm Bernstein Strategic Decisions Conference
05/06/2024 05:30 pm Jefferies Healthcare Conference
06/06/2024 11:30 am Vontobel Swiss Equity Leadership Conference
06/06/2024 11:30 am BNP Paribas Exane CEO Conference
11/06/2024 05:30 pm Goldman Sachs Global Healthcare Conference
18/06/2024 12:30 pm Citi European Healthcare Conference
25/07/2024 10:30 am Q2 2024 Earnings Release
25/07/2024 05:30 pm Q2 2024 Earnings Call
14/08/2024 05:30 pm UBS Genomic Medicine Summit
16/09/2024 03:30 pm Pharma Day

Past events on Roche Holding AG

24/04/2024 05:30 pm Q1 2024 Sales and Revenue Call
24/04/2024 10:30 am Q1 2024 Sales and Revenue Release
26/03/2024 01:30 pm BNP Exane Healthcare Conference
21/03/2024 01:30 pm Kepler Cheuvreux Swiss Seminar
14/03/2024 Ex-dividend day for final dividend
12/03/2024 07:30 pm Barclays Global Healthcare Conference
12/03/2024 03:00 pm Annual General Meeting
11/03/2024 07:30 pm Investor Meeting - Neurology
11/03/2024 HIMSS Conference
06/03/2024 08:30 pm TD Cowen Health Care Conference
27/02/2024 01:30 pm UBS European Healthcare Conference
25/02/2024 American Academy of Allergy, Asthma & Immunology Meeting
22/02/2024 10:30 pm Citi Oncology Leadership Summit
01/02/2024 06:30 pm Q4 2023 Earnings Call
01/02/2024 11:30 am Q4 2023 Earnings Release
11/01/2024 02:30 pm Octavian Seminar
09/01/2024 09:30 pm JPMorgan Healthcare Conference
12/12/2023 10:30 pm American Society of Hematology Meeting
12/12/2023 12:30 pm BNPP Exane DILS CEO Conference
12/12/2023 07:30 am American Society of Hematology Meeting - Abstract Number: #4090

Past dividends on Roche Holding AG

14/03/2024 Annual 9.6 CHF
16/03/2023 Annual 9.5 CHF
17/03/2022 Annual 9.3 CHF
18/03/2021 Annual 9.1 CHF
19/03/2020 Annual 9 CHF
07/03/2019 Annual 8.7 CHF
15/03/2018 Annual 8.3 CHF
16/03/2017 Annual 8.2 CHF
03/03/2016 Annual 8.1 CHF
05/03/2015 8 CHF

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
61 466
61 789
-0.52%
58 323
59 276
-1.61%
62 801
62 237
0.91%
63 281
63 332
-0.08%
58 716
59 502
-1.32%

60 042

EBITDA
Million CHF
Released
Forecast
Spread
25 419
24 199
5.04%
24 281
24 532
-1.02%
24 692
25 569
-3.43%
25 015
24 644
1.51%
21 976
22 765
-3.46%

22 783

EBIT
Million CHF
Released
Forecast
Spread
22 479
22 680
-0.89%
21 536
21 622
-0.4%
21 897
22 784
-3.89%
22 173
22 200
-0.12%
19 240
19 957
-3.59%

20 179

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
16 614
18 369
-9.56%
17 965
18 289
-1.77%
17 398
20 328
-14.41%
16 327
19 694
-17.1%
14 079
17 867
-21.2%

18 112

Net income
Million CHF
Released
Forecast
Spread
13 497
14 257
-5.33%
14 295
14 335
-0.28%
13 930
15 065
-7.53%
12 421
14 442
-13.99%
11 498
13 584
-15.35%

13 314

EPS
CHF
Released
Forecast
Spread
15,6
16,6
-5.73%
16,5
16,5
-0.02%
16,2
17,8
-9.22%
15,4
17,9
-14.08%
14,3
17,0
-15.74%

17,0

Announcement Date30/01/2004/02/2103/02/2202/02/2301/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 S1 2025 S2
Net sales
Million CHF
Released
Forecast
Spread
30 997
31 426
-1.37%
29 281
30 369
-3.58%
29 042
30 037
-3.31%
30 713
30 038
2.25%
16 117
15 745
2.36%
32 088
31 791
0.93%
16 445
16 072
2.32%
15 850
15 474
2.43%
32 295
31 869
1.34%
14 742
15 274
-3.48%
16 244
16 102
0.88%
30 986
30 807
0.58%
15 322
15 011
2.07%
14 457
14 534
-0.53%
29 779
29 914
-0.45%
14 274
14 256
0.13%

14 938

28 937
29 318
-1.3%
14 399
14 370
0.21%

14 540


29 055


14 690


15 015


29 705


15 320


30 630


30 615

EBIT
Million CHF
Released
Forecast
Spread
10 116
10 525
-3.89%
11 766
11 824
-0.49%
9 770
9 915
-1.46%
11 652
11 715
-0.53%



10 245
11 539
-11.21%






12 668
12 024
5.35%






9 505
9 639
-1.39%






10 911
11 057
-1.32%






8 329
9 168
-9.15%







10 443








9 916










Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
6 260
9 758
-35.85%
10 181
10 632
-4.24%
7 784
9 124
-14.68%
9 887
10 773
-8.22%



7 511
10 155
-26.04%






10 985
11 047
-0.56%






5 342
9 016
-40.75%






9 174
10 510
-12.71%






4 905
8 786
-44.17%







9 047








9 593










Net income
Million CHF
Released
Forecast
Spread
4 878
6 896
-29.26%
8 079
8 713
-7.27%
6 216
7 084
-12.25%
7 803
8 526
-8.48%



6 127
7 703
-20.46%






8 530
8 216
3.82%






3 891
6 862
-43.3%






7 137
7 896
-9.61%






4 361
6 781
-35.69%







6 723








7 251










EPS
CHF
Released
Forecast
Spread
5,63
7,56
-25.53%
9,32
9,70
-3.92%
7,20
8,06
-10.64%
9,05
9,29
-2.58%



7,15
9,30
-23.12%






10,5
10,0
5.14%






4,83
7,87
-38.6%






8,87
9,42
-5.81%






5,44
8,43
-35.47%







8,37








9,04










Announcement Date30/01/2023/07/2004/02/2122/07/2103/02/2203/02/2225/04/2221/07/2221/07/2218/10/2202/02/2302/02/2327/04/2327/07/2327/07/2301/11/23-01/02/24---------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise